Posted: Sun Jul 13, 2008 12:35 pm Post subject: Novartis Production Vaccine Capabilities
The Novartis facility in Holly Springs:
Construction started in the first quarter of 2007,
first phase scheduled for completion by the final quarter of 2008.
Expected to be validated by 2011–2012 and operational by 2013.
The first plant in the US to produce cell culture-derived flu vaccines.
Is expected to annually produce up to 50 million doses of seasonal trivalent flu vaccines.
And capacity of up to 150 million monovalent doses annually,
within six months of a pandemic declaration.
Novartis is also making investments in its site in Marburg, Germany http://www.pharmaceutical-technology.com/projects/novartis-vaccine/
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum